101 Therapeutics Releases Clinical Evidence Package for Macrophage-Targeted 101-PGC-005 and Seeks Urgent Independent Review for Bundibugyo Ebola Disease 101 Therapeutics Ltd. today announced the public release of its clinical and scientific evidence package for 101-PGC-005 (‘005), a macrophage-targeted dexamethasone prodrug…
Blooming Future Launches Operations as Part of Braskem’s Expanding Sustainable Fleet Braskem the largest polyolefins producer in the Americas and global leader in the production of biopolymers on an industrial scale announces that Braskem Trading & Shipping (BT&S) has launched the…
Laprophan Completes the Acquisition of Rivopharm, Accelerating Its International Expansion Strategy Laprophan Group, the pioneer and one of Morocco’s leading pharmaceutical groups, announced the successful completion of the acquisition of a controlling stake in Rivopharm, a Switzerland-based pharmaceutical company specialized in…
Real Chemistry Unifies Omnichannel Offering as Real Chemistry Media, a Technology-led, Healthcare-focused Practice of the Future Real Chemistry, a leader in AI-driven insights and marketing and communications exclusively for the healthcare and life sciences sectors, announced the full integration of…
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress CareDx, Inc. The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value…
Osmo To Sell 10 Proprietary AI-Developed Fragrance Ingredients In First-of-its-Kind Auction Osmo, the olfactory technology company, announced the first-ever auction of fragrance captives, offering exclusive, perpetual licenses to 10 proprietary molecules developed through its Olfactory Intelligence platform. Launching at the…
Komodo Health Evolves Leadership Structure and Names Miles Ennis President Komodo Health®, the leader in AI-powered healthcare intelligence, announced an evolution of its executive leadership structure to accelerate the company’s next phase of growth and reinforce its position as the…
Pelago Bioscience acquires RG Discovery, forming an integrated drug discovery partner covering biology and chemistry Pelago Bioscience, a contract research organization (CRO) specializing in drug discovery and renowned for its cutting-edge cell target engagement assays, is pleased to announce the…
cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation The Collaborative Trajectory Analysis Project (cTAP) announces the publication of a novel, validated prognostic score for predicting the loss of ambulation (LoA)…
New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1 Takeda presented additional results from two pivotal studies at SLEEP 2026, showing oveporexton (TAK-861), an oral orexin receptor 2 (OX2R)-selective…
Pyxis Group, Principia Consulting, and CommodityAI Partner to Bring Agentic AI to Commodity Operations Pyxis Group, a global advisory firm serving the commodities industry, together with its joint venture partner Principia Consulting, announced a strategic partnership with CommodityAI, the agentic…
Onera Will Showcase Its Onera hPSG® Solution at the SLEEP 2026 Conference June 14-17, 2026 in Baltimore, MD, USA. Onera Health, a leader in transforming sleep medicine, announces that its end-to-end home polysomnography solution, the Onera hPSG® solution, will be prominently…